These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2898343)

  • 1. Cyclosporine-phenytoin interaction.
    D'Souza MJ; Pollock SH; Solomon HM
    Drug Metab Dispos; 1988; 16(2):256-8. PubMed ID: 2898343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine-cimetidine interaction.
    D'Souza MJ; Pollock SH; Solomon HM
    Drug Metab Dispos; 1988; 16(1):57-9. PubMed ID: 2894956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats.
    Pollock SH; Matthews HW; D'Souza MJ
    Drug Metab Dispos; 1989; 17(6):595-9. PubMed ID: 2575493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and biotransformation of the cyclosporine metabolite M-17 in the rabbit.
    Copeland K; Lukowski M; Yatscoff R; Thliveris J; Honcharik N
    Drug Metab Dispos; 1990; 18(2):226-30. PubMed ID: 1971578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine disposition in the dog. Comparison of radioimmunoassay with high-performance liquid chromatographic assay and pharmacokinetics following intravenous administration.
    Buice RG; Gurley BJ; Stentz FB; Sidhu P; McClellan T; Williams JW
    Transplantation; 1985 Nov; 40(5):483-8. PubMed ID: 4060219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats.
    Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
    J Pharm Pharmacol; 2004 Apr; 56(4):477-83. PubMed ID: 15099443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin.
    Ducharme MP; Slaughter RL; Warbasse LH; Chandrasekar PH; Van de Velde V; Mannens G; Edwards DJ
    Clin Pharmacol Ther; 1995 Dec; 58(6):617-24. PubMed ID: 8529326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.
    Bruelisauer A; Kawai R; Misslin P; Lemaire M
    Drug Metab Dispos; 1994; 22(2):194-9. PubMed ID: 8013274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients.
    Ost L
    Transplantation; 1987 Oct; 44(4):533-5. PubMed ID: 3313841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
    Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG
    Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased phenytoin metabolism in rabbits after phenytoin pretreatment.
    Wilensky AJ; Lowden JA
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):365-8. PubMed ID: 981792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tubular transport of cyclosporine A (CSA) and associated changes in renal function.
    Caterson RJ; Duggin GG; Critchley L; Baxter C; Horvath JS; Hall BM; Tiller DJ
    Clin Nephrol; 1986; 25 Suppl 1():S30-3. PubMed ID: 3519028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.
    D'mello A; Venkataramanan R; Satake M; Todo S; Takaya S; Ptachcinski RJ; Burckart GJ; Starzl TE
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):441-54. PubMed ID: 2781141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampin and ansamycin interactions with cyclosporine after renal transplantation.
    Vandevelde C; Chang A; Andrews D; Riggs W; Jewesson P
    Pharmacotherapy; 1991; 11(1):88-9. PubMed ID: 2020617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
    Frey BM; Sieber M; Mettler D; Gänger H; Frey FJ
    Drug Metab Dispos; 1988; 16(2):285-9. PubMed ID: 2898348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine metabolite disposition after oral administration in pretransplant end-stage renal disease patients.
    Alexander DP; Horning L; Bowers LD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):499-508. PubMed ID: 3284097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
    Fabre I; Fabre G; Maurel P; Bertault-Peres P; Cano JP
    Drug Metab Dispos; 1988; 16(2):296-301. PubMed ID: 2898350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin-phenytoin interaction: re-evaluation using metabolite data.
    Rowland M; Gupta SK
    Br J Clin Pharmacol; 1987 Sep; 24(3):329-34. PubMed ID: 3663449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine kinetics in healthy volunteers.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Gray JA; Van Thiel DH; Sanghvi A; Rosenthal JT
    J Clin Pharmacol; 1987 Mar; 27(3):243-8. PubMed ID: 3680581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites.
    Freeman DJ; Laupacis A; Keown PA; Stiller CR; Carruthers SG
    Br J Clin Pharmacol; 1984 Dec; 18(6):887-93. PubMed ID: 6529529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.